REGN trade ideas
Stocks may quickly rise to Targets when there are few resistanceTARGET 1 Price: 410.99 Profit: 12.8% (Typical rally)
Stop/Trailing Stop: 351.3 Loss: 3.6%
P/L Ratio: 3.6 : 1 - Good
POTENTIAL Excellent, there are 1 resistance areas on the way to Target 1.
Stocks may quickly rise to Targets when there are few resistance areas
REGN- Nice Looking ABC To Multiple Supports4-1 Nice looking ABC to multiple supports.
As long as this issue stays above the blue and
green support lines all is well. This level also
happens to be near the 50 day SMA.
If you like these kind of chart set ups
don't forget to follow me here or on TWTR at
@AmazingPatterns
For educational and informational use only,
these are not recomendations , trade at
your own risk
Double ToipREGN is doing a double top and it's at the Upper Channel Resistance level, If it is not able to break this level to the upside, then it will retrace to probably the mid channel line, and eventually if market in general falls it can go to the lower channel support line. There is a negative momentum divergence, which is the signature of a downtrend.
Entry: 386, Target 340, Stop: 410, Risk/Reward Ratio 2
REGN- See How Important The Use Of Trend Channels Are? 10-30 For those interested in buying support,
especially know considering how short term
extended things are these days. Its all about the blue line.
It also helps define ones entry risk here. If buying here
you are buying 20 points away from a support zone
(thanks anyway I say). Given this issue is tagging a
trend channel resistance zone? That is all the more
reason to let them come to you in the form of a pullback.
After all to a chartist the adage of buy support and sell
resistance is a classic mantra isn't it? Even more so
when you have an issue that just tagged the trend
channel resistance zone. Sure its pulling back but still
needs more chart time. This chart is also a good
example of how the trend channel keeps you away
from going long at the wrong time and AFTER a run
has been made already.
The use of trend channels are your best friend.
Not only do they help you manage the overall
trend they keep you from getting emotional at
key levels. At resistance? They keep you away
from that dreaded fear of missing it AFTER you
already missed it emotional trade. At support
they keep you away from caving into fear and
selling at a support zone.
For informational and educational purposes only.
These are not recommendations. Trade at your own risk.
Extremely vulnerable Bulls!Using a normal arithmetic scale chart, this healthcare stock has been in gradual parabolic movement until we get a Hanging Man at the top (though monthly candle for Oct is not complete yet)
Besides, the price is also at the channel top. But RSI is showing a potential bearish divergence.
I saw this weakness.
What is the chances of bull winning when this LAST bull has to deal with a large herd of bears waiting
If you've been waiting to get long REGN, now is the time.It got beaten so badly because of some analyst's note saying that REGN's blockbuster eye drug Eylea has been replaced by cheaper rival drugs. First, it was only rumored to be "10%" of total patients, secondly, its rheumatoid arthritis drug "sarilumab" that is under development with Sanofi is showing promising signs and is now in phase 3. Overall, reaction is a little overblown IMO, we can expect a bounce from here.
Regeneron Long-term Trend Remains Intact.Many sector leaders like Gilead, Celgene, and Biogen all had a nice run up at the end of the week, which is encouraging given people tend to sell on Friday, especially in this market.
This bad boy went berserk in April 2013, flied away from this trend line and entered into a channel, which by the way, it broke exactly one year later, April 2014. Since then Regeneron had fallen back to this trend line, and it tested the high 270s support 3 times in the past month and successfully rebounded. I do believe the biotech selloff is over, however, a further selloff of other momo stocks(TWTR, TSLA, etc.)this week spoiled the party and botched this long anticipated revocery. But this doesn't mean the party is over, it just means it's postponed.
Plus, a big plus, Sanofi bought god knows how many shares of REGN at 310 in March and now owns a big chunk(30% ?) of the company. If Sanofi thought 310$ a share was fair, what's holding us back from snapping up REGN 280$ a share? And given the current M&A frenzy, who knows right?